A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
Rocky Mountain Cancer Centers (RMCC) is Colorado’s largest and most comprehensive provider of cancer care with 53 physicians, in more than 20 community-based locations across the state. RMCC history is rich in forward thinking and best practice development.
Boulder, Colorado Clinical Trial Location
Rocky Mountain Cancer Centers
4715 Arapahoe Ave,
Boulder, CO 80303